ID

17421

Beschrijving

Novel Treatment for Diastolic Heart Failure in Women; ODM derived from: https://clinicaltrials.gov/show/NCT00206232

Link

https://clinicaltrials.gov/show/NCT00206232

Trefwoorden

Versies (1)
  1. 13-09-16 13-09-16 -
Geüploaded op

13 september 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Heart Failure NCT00206232

Engels

Eligibility Heart Failure NCT00206232

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
women who are 18 years of age or older.
Beschrijving

Gender | Age

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
women with clinical heart failure for > 2 months.
Beschrijving

Gender | Heart failure Clinical

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0018801
UMLS CUI [2,2]
C0205210
women with left ventricular ejection fraction > 50% within 2 months of screening.
Beschrijving

Gender | Left ventricular ejection fraction

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0428772
women with new york heart association class ii or iii heart failure symptoms.
Beschrijving

Gender | Symptoms heart failure | New York Heart Association Classification

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C2735647
UMLS CUI [3]
C1275491
brain natriuretic peptide > 62 pg/ml within 2 months of screening.
Beschrijving

Brain natriuretic peptide measurement

Datatype

boolean

Alias
UMLS CUI [1]
C1095989
patient on angiotensin converting enzyme inhibitor or angiotensin receptor blocker therapy for at least 1 month.
Beschrijving

Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist

Datatype

boolean

Alias
UMLS CUI [1]
C0003015
UMLS CUI [2]
C0521942
blood pressure no more than 150/95.
Beschrijving

Blood Pressure

Datatype

boolean

Alias
UMLS CUI [1]
C0005823
patient able to walk more than 50 meters at the time of enrollment.
Beschrijving

Able to walk Walking distance

Datatype

boolean

Alias
UMLS CUI [1,1]
C2712089
UMLS CUI [1,2]
C0429886
signed informed consent.
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
current treatment with spironolactone.
Beschrijving

Spironolactone

Datatype

boolean

Alias
UMLS CUI [1]
C0037982
severe hepatic impairment.
Beschrijving

Hepatic impairment Severe

Datatype

boolean

Alias
UMLS CUI [1,1]
C0948807
UMLS CUI [1,2]
C0205082
creatinine > 2.5 mg/dl
Beschrijving

Creatinine measurement, serum

Datatype

boolean

Alias
UMLS CUI [1]
C0201976
potassium > 5.0 meq/l
Beschrijving

Potassium measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0202194
intolerance to spironolactone in the past.
Beschrijving

intolerance to Spironolactone

Datatype

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0037982
significant valvular heart disease, pericardial disease, or severe chronic lung disease with cor pulmonale.
Beschrijving

Heart valve disease Significant | Disorder of pericardium | Severe chronic lung disease | Cor pulmonale

Datatype

boolean

Alias
UMLS CUI [1,1]
C0018824
UMLS CUI [1,2]
C0750502
UMLS CUI [2]
C0265122
UMLS CUI [3]
C3278799
UMLS CUI [4]
C0034072
unstable angina or myocardial infarction within the past 4 weeks.
Beschrijving

Angina, Unstable | Myocardial Infarction

Datatype

boolean

Alias
UMLS CUI [1]
C0002965
UMLS CUI [2]
C0027051
severe peripheral vascular disease or other physical conditions that would limit the walking distance.
Beschrijving

Peripheral Vascular Disease Severe Limiting Walking distance | Physical Condition Limiting Walking distance

Datatype

boolean

Alias
UMLS CUI [1,1]
C0085096
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0439801
UMLS CUI [1,4]
C0429886
UMLS CUI [2,1]
C3714565
UMLS CUI [2,2]
C0439801
UMLS CUI [2,3]
C0429886
pregnant or lactating females.
Beschrijving

Pregnancy | Breast Feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
participation in any other drug trial within 30 days prior to randomization.
Beschrijving

Study Subject Participation Status

Datatype

boolean

Alias
UMLS CUI [1]
C2348568
inability to provide informed consent.
Beschrijving

Informed Consent Unable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
Terug naar het begin van de pagina

Similar models

Eligibility Heart Failure NCT00206232

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
women who are 18 years of age or older.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Gender | Heart failure Clinical
Item
women with clinical heart failure for > 2 months.
boolean
C0079399 (UMLS CUI [1])
C0018801 (UMLS CUI [2,1])
C0205210 (UMLS CUI [2,2])
Gender | Left ventricular ejection fraction
Item
women with left ventricular ejection fraction > 50% within 2 months of screening.
boolean
C0079399 (UMLS CUI [1])
C0428772 (UMLS CUI [2])
Gender | Symptoms heart failure | New York Heart Association Classification
Item
women with new york heart association class ii or iii heart failure symptoms.
boolean
C0079399 (UMLS CUI [1])
C2735647 (UMLS CUI [2])
C1275491 (UMLS CUI [3])
Brain natriuretic peptide measurement
Item
brain natriuretic peptide > 62 pg/ml within 2 months of screening.
boolean
C1095989 (UMLS CUI [1])
Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist
Item
patient on angiotensin converting enzyme inhibitor or angiotensin receptor blocker therapy for at least 1 month.
boolean
C0003015 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
Blood Pressure
Item
blood pressure no more than 150/95.
boolean
C0005823 (UMLS CUI [1])
Able to walk Walking distance
Item
patient able to walk more than 50 meters at the time of enrollment.
boolean
C2712089 (UMLS CUI [1,1])
C0429886 (UMLS CUI [1,2])
Informed Consent
Item
signed informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Spironolactone
Item
current treatment with spironolactone.
boolean
C0037982 (UMLS CUI [1])
Hepatic impairment Severe
Item
severe hepatic impairment.
boolean
C0948807 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Creatinine measurement, serum
Item
creatinine > 2.5 mg/dl
boolean
C0201976 (UMLS CUI [1])
Potassium measurement
Item
potassium > 5.0 meq/l
boolean
C0202194 (UMLS CUI [1])
intolerance to Spironolactone
Item
intolerance to spironolactone in the past.
boolean
C1744706 (UMLS CUI [1,1])
C0037982 (UMLS CUI [1,2])
Heart valve disease Significant | Disorder of pericardium | Severe chronic lung disease | Cor pulmonale
Item
significant valvular heart disease, pericardial disease, or severe chronic lung disease with cor pulmonale.
boolean
C0018824 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0265122 (UMLS CUI [2])
C3278799 (UMLS CUI [3])
C0034072 (UMLS CUI [4])
Angina, Unstable | Myocardial Infarction
Item
unstable angina or myocardial infarction within the past 4 weeks.
boolean
C0002965 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
Peripheral Vascular Disease Severe Limiting Walking distance | Physical Condition Limiting Walking distance
Item
severe peripheral vascular disease or other physical conditions that would limit the walking distance.
boolean
C0085096 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
C0429886 (UMLS CUI [1,4])
C3714565 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0429886 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
pregnant or lactating females.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status
Item
participation in any other drug trial within 30 days prior to randomization.
boolean
C2348568 (UMLS CUI [1])
Informed Consent Unable
Item
inability to provide informed consent.
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial